Abstract
Colon cancer is a leading cause of cancer death worldwide. Although the survival of patients with metastatic disease has improved with the use of systemic therapy, many of them develop primary resistance with progression within a few months. Despite the genomic characterization of these tumors has positively influenced the therapy offered, it is still a challenge to identify alterations t…